Clinical Trial Update: The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors [EARLY_Phase 1]

View source ↗

Summary

This early-phase (Phase 1) trial assesses the safety, dosimetry, and preliminary efficacy signals of the radiopharmaceutical 177Lu-INN805 in patients with malig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Head and Neck Cancer
• Non-small Cell Lung Cancer
• Sarcoma
• Thyroid Cancer

Drugs mentioned

• 177Lu-INN805 (INN805 radiopharmaceutical)

Snippet

Sponsor: FindCure Biosciences (ZhongShan) Co., Ltd. | Conditions: Maligant Solid Tumor, Head & Neck Cancer | EARLY_Phase 1 | Status: NOT_YET_RECRUITING